Get our Free Patent Expiration Newsletter

Serving leading biopharmaceutical companies globally:

AstraZeneca
Express Scripts
Medtronic
Mallinckrodt
Dow
Boehringer Ingelheim

Last Updated: November 21, 2019

DrugPatentWatch Database Preview

Litigation Details for Baker v. Bayer Aktiengescellschaft Corporation (W.D. Tenn. 2010)

See Plans and Pricing

« Back to Dashboard

Baker v. Bayer Aktiengescellschaft Corporation (W.D. Tenn. 2010)

Docket   Start Trial Date Filed 2010-04-13
Court District Court, W.D. Tennessee Date Terminated 2011-01-20
Cause 35:271 Patent Infringement Assigned To Jon Phipps McCalla
Jury Demand Plaintiff Referred To Magistrate Judge Tu M. Pham
Parties BAYER AKTIENGESCELLSCHAFT CORPORATION; BAYER CORPORATION; BAYER HEALTHCARE PHARMACEUTICALS, INC; BAYER HEALTHCARE, LLC; CHARLES R. BAKER
Patents 4,357,324; 4,670,444; 4,844,902
Attorneys Bradford J. Badke; Glen G. Reid , Jr.; Jeanne C. Curtis; Kirk A. Caraway; Matthew A. Traupman
Firms Ropes and Gray LLP
Link to Docket External link to docket
Small Molecule Drugs cited in Baker v. Bayer Aktiengescellschaft Corporation
The small molecule drugs covered by the patents cited in this case are   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial , and   Start Trial .

Details for Baker v. Bayer Aktiengescellschaft Corporation (W.D. Tenn. 2010)

Date Filed Document No. Description Snippet Link To Document
2010-04-13 1 United States patent number 4,357,324 (hereinafter referred to as the “ ‘324 Patent”). … 90. United States Patent Number 4,357,324 was filed on February 24, 1981, and issued…November 2, 1982. (Please see United States Patent No. 4,357,324, attached hereto as Exhibit ‘F’). … ‘787 Patent, ‘790 Patent, ‘377 Patent, ‘234 Patent, ‘798 Patent, ‘332 Patent, and ‘314 Patent have all… ‘787 Patent, ‘790 Patent, ‘377 Patent, ‘234 Patent, ‘798 Patent, ‘332 Patent, and ‘314 Patent, each External link to document
2010-06-10 21 Exhibit Patent 4,844,902, # 5 Exhibit Patent 4,357,324, # 6 Exhibit Fludara Label, # 7 Exhibit Patent 4,808,576…Attachments: # 1 Exhibit Patent 4,670,444, # 2 Exhibit Certificate of Extending Patent Term, # 3 Exhibit Cipro…2010 20 January 2011 2:10-cv-02271 830 Patent Plaintiff District Court, W.D External link to document
2010-06-14 23 Exhibit Patent 4,844,902, # 5 Exhibit Patent 4,357,324, # 6 Exhibit Fludara Label, # 7 Exhibit Patent 4,808,576…Attachments: # 1 Exhibit Patent 4,670,444, # 2 Exhibit Certificate Extending Patent Term, # 3 Exhibit Cipro…2010 20 January 2011 2:10-cv-02271 830 Patent Plaintiff District Court, W.D External link to document
>Date Filed >Document No. >Description >Snippet >Link To Document

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

McKesson
AstraZeneca
Moodys
Baxter
Dow
Medtronic

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.